|
|
|
|
Vol. 58, Issue 5, 1057-1066, November 2000
National Research Institute of Chinese Medicine (Y.-C.K., C.-J.C.,
L.-C.L., W.-J.T.), Institute of Biology (Y.-C.K., N.-S.Y.), Fu-Jen
University, Taipei, Taiwan, Republic of China
Effects of piperlactam S
(C17H13NO4; mol. wt. 295) isolated
from Piper kadsura on phytohemagglutinin (PHA)
stimulated cell proliferation were studied in primary culture of human
T cells. The results showed that piperlactam S suppressed T cell
proliferation at about 0 to 12 h after stimulation with PHA.
Synthesis of total cellular proteins and RNA in activated cell cultures
was also suppressed. The inhibitory action of piperlactam S was not
through direct cytotoxicity. Cell cycle analysis indicated that
piperlactam S arrested the cell cycle progression of activated T cells
from the G1 transition to the S phase. In an attempt
to further localize the point in the cell cycle at which arrest
occurred, a set of key regulatory events leading to the
G1/S boundary, including gene expression of
cytokines and c-Fos protein synthesis, was examined. Piperlactam S
suppressed, in activated T lymphocytes, the production and mRNA
expression of cytokines such as interleukin-2 (IL-2), IL-4, and
interferon-
in a dose-dependent manner. In addition, Western blot
analysis indicated that c-Fos protein expressed in activated T
lymphocytes was decreased by piperlactam S. Results of kinetic study
indicated that inhibitory effects of piperlactam S on IL-2 mRNA
expressed in T cells might be related to blocking c-Fos protein
synthesis. Thus, the suppressant effects of piperlactam S on
proliferation of T cells activated by PHA seemed to be mediated, at
least in part, through inhibition of early transcripts of T cells,
especially those of important cytokines, IL-2, IL-4, and arresting cell
cycle progression in the cells.
This article has been cited by other articles:
![]() |
J. M. Escandell, M. C. Recio, S. Manez, R. M. Giner, M. Cerda-Nicolas, R. Gil-Benso, and J.-L. Rios Dihydrocucurbitacin B Inhibits Delayed Type Hypersensitivity Reactions by Suppressing Lymphocyte Proliferation J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1261 - 1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-P. Liu, Y.-C. Kuo, C.-C. Shen, M.-H. Wu, J.-F. Liao, Y.-L. Lin, C.-F. Chen, and W.-J. Tsai (S)-Armepavine inhibits human peripheral blood mononuclear cell activation by regulating Itk and PLC{gamma} activation in a PI-3K-dependent manner J. Leukoc. Biol., May 1, 2007; 81(5): 1276 - 1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Agnati, S. Ferre, C. Lluis, R. Franco, and K. Fuxe Molecular Mechanisms and Therapeutical Implications of Intramembrane Receptor/Receptor Interactions among Heptahelical Receptors with Examples from the Striatopallidal GABA Neurons Pharmacol. Rev., September 1, 2003; 55(3): 509 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Kuo, L.-C. Lin, W.-J. Tsai, C.-J. Chou, S.-H. Kung, and Y.-H. Ho Samarangenin B from Limonium sinense Suppresses Herpes Simplex Virus Type 1 Replication in Vero Cells by Regulation of Viral Macromolecular Synthesis Antimicrob. Agents Chemother., September 1, 2002; 46(9): 2854 - 2864. [Abstract] [Full Text] [PDF] |
||||